NCT00305786View on ClinicalTrials.gov

Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

May 31, 2010

Conditions
Lung Cancer
Interventions
DRUG

gemcitabine hydrochloride

DRUG

oxaliplatin

Trial Locations (2)

33136

University of Miami Sylvester Comprehensive Cancer Center - Miami, Miami

33612-9497

H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa

All Listed Sponsors
lead

University of Miami

OTHER

NCT00305786 - Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter